$TURV TWO RIVERS WATER & FARMING ENTERS INTO AGREEMENT TO

New Post Public Reply Private Reply Replies (0) Message Board
hotforpenny
624
$TURV
TWO RIVERS WATER & FARMING ENTERS INTO AGREEMENT TO ACQUIRE HEMP-FOCUSED COMPANIESPress Release | 02/25/2019

Planning underway with three acquisitions
for growing hemp on land owned and water supplied by Two Rivers, along with processing and selling hemp-based products

DENVER, Colorado, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Two Rivers Water & Farming Company (OTCQB: TURV) has entered into an agreement (the “Agreement”) to purchase three hemp-focused businesses – Vaxa Global, LLC (“Vaxa”); Ekstrak Labs LLC (“Ekstrak”) and Gramz Holdings, LLC (“Gramz”) – from EASBY Land & Cattle Company, LLC (“EASBY”).

“We are excited about the potential synergies of our acquisition of Vaxa, Ekstrak and Gramz,” commented Wayne Harding, Chief Executive Officer of Two Rivers. “Vaxa, Ekstrak and Gramz are expanding into the Western United States. Vaxa is planning to grow hemp on land owned and water supplied by Two Rivers. Ekstrak is the lab and extraction facilities. Gramz provides end user products. Taken as a whole, we are one of the few companies that plan to be vertically integrated in the hemp space – from seed to products.”

Greg Harrington, Managing Member of EASBY commented, “It has been an exciting road watching and being part of the reemergence and growth of hemp. The hemp plant has so many uses, and our companies’ direction is to continue to introduce the highest quality hemp and CBD products available. Vaxa holds to its core competency, with new brands, vertical markets and ability to place products in retailers, both large and small. This agreement with Two Rivers brings us great enthusiasm for the future.

“We feel this Agreement with Two Rivers will better position our combined entities’ ability for long term, sustainable growth within our vertical markets. Together we amplify our move into health, beverage, natural foods, and beauty related-products. We will continue to innovate and grow awareness within the hemp, agriculture and water space. It is great to know that our investors and customers can now be part of our mission and success.”

Under the Agreement, Two Rivers will issue 30,000,000 shares of its common stock to EASBY at closing and, pursuant to an earn-out provision, may issue up to an additional 20,000,000 shares based on EBITDA generated by the acquired companies over the twelve months ending March 31, 2020.

The closing must occur on or before April 15, 2019, unless otherwise agreed upon by Two Rivers and EASBY. The closing is subject to standard conditions, as well as a requirement that Two Rivers enter into an agreement with TR Capital Partners, LLC members under which all of the outstanding preferred units of TR Capital Partners will be exchanged for shares of Two Rivers common stock.

The full agreement will be posted to www.sec.gov with a Current Report on From 8-K shortly after this release.

About Two Rivers

Two Rivers (www.2riverswater.com) assembles its water assets by acquiring land with senior water rights. Two Rivers focuses on development and redevelopment of infrastructure for water management and delivery. Water is one of the most basic, core assets. Two Rivers’ first area of focus is in the Huerfano-Cucharas river basin in southeastern Colorado. Two Rivers’ long-term strategy focuses on the value of our water assets and how to monetize water for the benefit of its stakeholders, including communities near where its water assets are located. Currently, Two Rivers is focused on expanding their agriculture activity through growing hemp along with development and rehabilitation of its water assets.

About Vaxa Global, LLC

Vaxa Global, LLC (www.vaxaglobal.com) distributes Canadian grown patented-processed hemp for CBD extraction within the United States to states that are approved to extract CBD. Vaxa hemp is 100% organic, non-GMO, solvent free, THC free, 100% food-grade edible, and has the Canadian Department of Agriculture Hemp Seal of Approval. Vaxa plans to expand their agricultural activities to the Western United States. Vaxa Global has transitioned from one of the first industrial hemp distributors/farmers/manufactures from Canada into the US. Through its wholly owned subsidary GRAMZ is known for high quality Hemp and CBD products.

About Ekstrak Labs, LLC

Ekstrak Labs, LLC. (www.ekstraklabs.com) is an emerging company in the extraction industry, dedicated to creating high quality extraction labs around the United States. Eskstrak builds state-of-the-art facilities with machinery that is proven to delivery optimal extraction results. Eskstrak offers joint venture partnerships for brand diversification into various products that are top performers in the marketplace. Ekstrak’s R&D division creates innovative product line for our affiliated brands as well as white label wholesale products.

About Gramz Holdings, LLC

Gramz Holdings, LLC (www.getgramz.com) is a leading supplier, and first-to-market Nature’s Whole Spectrum™, natural whole plant compounds in delivery systems committed to maintaining the composition of the plant’s natural source and state. Gramz™ was founded to honor and respect the true medicinal and therapeutic value of hemp’s whole plant composition. Through their commitment to providing research-based products that maintain the integrity of their natural source, Gramz™ continuously evolves as technology presents itself, and educates people on the fundamental benefits of whole plant compounds. Gramzs™ products include Gramz Whole Plant Matrix™ Sublingual Drops and Gramz Herbal Topical and Gramz, with R&D in progress for pain releaf, sleep and anxiety products as well as pet-health-based products.

Two Rivers Water Co. (TURV) Stock Research Links

TURV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 7

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 5

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 3

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 5

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 4

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Shell plc: Recent Share Transactions by Management Team

Updated Category News Views 110

Shell plc made some serious moves back in September 2024 that had traders scratching their heads and looking for the fine print. They let loose a slew of notifications about share transactions by its Persons Discharging Managerial Responsibilities (PDMRs), making waves in the market. This isn’t just corporate fluff; it’s a playbook for transparency and compliance that...

Continue Reading
zSpace Faces Class Action Over IPO Missteps: Key Probe

Updated Category News Views 5

Unpacking the Explosive Allegations Against zSpace You think you're safe diving into augmented reality stocks, and then a bombshell lands. zSpace, Inc. (NASDAQ:ZSPC), a supposed leader in AR and VR educational tech, finds itself in the swirling midst of a class action lawsuit. Investors are rattled, and they're not just buzzing because their portfolios took a hit. There's...

Continue Reading
Transforming Spending: WisdomTree's Innovative Feature Launch

Updated Category News Views 164

WisdomTree Introduces Earn-Until-You-Spend Feature WisdomTree, Inc. (NYSE: WT), a leader in financial innovation, has recently announced a significant enhancement to its user experience with the introduction of a new feature allowing customers to utilize their accrued interest from the WisdomTree Government Money Market Digital Fund (WTGXX) as a funding source for the...

Continue Reading
AVITA Medical Set to Share Third Quarter 2025 Results Soon

Updated Category News Views 163

AVITA Medical to Report Financial Results AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a prominent company in therapeutic acute wound care, has made headlines with its upcoming financial disclosure. The firm is set to unveil its third-quarter financial results for 2025 after the U.S. markets close on the scheduled date. This announcement is anticipated by investors who...

Continue Reading
Hyperscale Data Celebrates Sustainable Growth with Dividends

Updated Category News Views 45

Hyperscale Data's Commendable Dividend Achievement LAS VEGAS — Hyperscale Data, Inc. (NYSE: GPUS) proudly announced it has consistently paid cash dividends for twenty-eight consecutive months on its Series D Preferred Stock. This dividend, amounting to 13.00% annually, equates to approximately $0.2708 for each share, paid monthly. This remarkable track record...

Continue Reading